Kisspeptin and neurokinin B neuroendocrine pathways in the control of human ovulation.
Anderson. Richard A RA
Key Findings
- Kisspeptin mediates the switch to positive estrogen feedback, boosting GnRH release that leads to the LH surge and ovulation.
- Neurokinin B is crucial for the precise hypothalamic control of gonadotropin release needed for mono‑ovulation.
- Targeting these pathways could become new treatments for reproductive disorders such as PCOS, functional hypothalamic amenorrhoea, and to improve IVF protocols.
Practical Outcomes
- For most biohackers, the information is not yet ready for direct self‑experimentation because no dosing guidelines or approved supplements are discussed. However, it highlights that future drugs affecting kisspeptin or neurokinin B may influence fertility and menstrual health, which could become relevant for those tracking reproductive performance or seeking hormonal optimization.
Summary
This review explains how two brain chemicals, kisspeptin and neurokinin B, help control the hormone signals that make an egg mature and trigger ovulation. It shows that kisspeptin ramps up GnRH (a key hormone) when estrogen switches from a negative to a positive signal, while neurokinin B fine‑tunes the hormone drive needed for a single egg release. The paper also talks about early drug ideas for conditions like PCOS, missed periods, and IVF support.
Abstract
The roles of initially kisspeptin and subsequently neurokinin B pathways in the regulation of human reproduction through the control of GnRH secretion were first identified 20 years ago, as essential for the onset of puberty in both boys and girls. Within that short time we already now have the first licence for clinical use for a neurokinin antagonist in a related indication, for menopausal vasomotor symptoms. Between these two markers of the start and end of the reproductive lifespan, it is clear that these pathways underlie many of the aspects of the hypothalamic regulation of reproduction which had hitherto been enigmatic. In this review, we describe the data currently available from studies designed to elucidate the roles of kisspeptin and neurokinin B in human ovarian function, specifically the regulation of follicle development leading up to ovulation, and in the control of the mid-cycle GnRH/LH surge that triggers ovulation. These studies, undertaken with only very limited pharmacological tools, provide evidence that the neurokinin B pathway is important in controlling the hypothalamic contribution to the precise gonadotropic drive to the ovary that is necessary for mono-ovulation, whereas the switch from negative to positive estrogenic feedback results in kisspeptin-mediated increased GnRH secretion. Potential therapeutic opportunities in conditions characterised by disordered hypothalamic/pituitary function, polycystic ovary syndrome, and functional hypothalamic amenorrhoea, and in the induced LH surge that is a necessary part of IVF treatment are discussed.
Study Information
pubmed
2024
2024-02-25T00:00:00.000Z
10.1111/jne.13371
4
39